Share Your Story

Share your story and help other adults learn about XELJANZ/XELJANZ XR. Learning about your experience with XELJANZ/XELJANZ XR may be helpful for patients who are considering treatment or have already started. If selected, your story may appear on XELJANZ.com and/or in other marketing materials.

  • Moderate to SevereRheumatoid Arthritis
  • ActivePsoriatic Arthritis
  • Moderate to SevereUlcerative Colitis

IN ORDER TO SUBMIT YOUR STORY, YOU MUST:

  • Be 18 years or older
  • Not be enrolled in a current Pfizer clinical trial
  • Have taken methotrexate in the past or are currently taking it
  • Have been diagnosed with moderate to severe RA
  • Have been taking XELJANZ or XELJANZ XR for a minimum of 8 weeks
  • Be a resident of the United States
  • Be 18 years or older
  • Not be enrolled in a current Pfizer clinical trial
  • Have taken or are currently taking methotrexate or other similar medicines called nonbiologic disease-modifying antirheumatic drugs (DMARDs)*
  • Have been diagnosed with active psoriatic arthritis
  • Have been taking XELJANZ or XELJANZ XR for your active psoriatic arthritis in combination with a nonbiologic DMARD*
  • Be a resident of the United States
*Methotrexate, sulfasalazine, or leflunomide
  • Be 18 years or older
  • Not be enrolled in a current Pfizer clinical trial
  • Have been diagnosed with moderate to severe ulcerative colitis
  • Have taken a tumor necrosis factor (TNF) blocker before XELJANZ or XELJANZ XR
  • Have been taking XELJANZ or XELJANZ XR for a minimum of 8 weeks
  • Be a resident of the United States